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Human bocavirus (HBoV), a new member of the genus
Bocavirus in the family Parvoviridae, has been recently
associated with respiratory tract infections. We report the
epidemiologic and clinical features observed from a 1-year
retrospective study of HBoV infection in young children
hospitalized with a respiratory tract infection.
V
iral respiratory tract infections cause a substantial
amount of illness and death in children. Respiratory
syncytial virus (RSV), influenza A and B viruses, parain-
fluenza viruses, human adenoviruses, rhinoviruses, coron-
aviruses, and the more recently identified human
metapneumovirus (HMPV) all cause respiratory tract
infections. However, in a substantial proportion of respira-
tory tract infections, no etiologic agent is detected (1),
which suggests unknown pathogens. A previously
unknown virus likely involved in children’s respiratory
tract infections has been recently described in Sweden (2)
and was also identified in Australia (3) and Japan (4). This
newly identified virus shares a high sequence identity and
a similar genomic organization with bovine parvovirus and
canine minute virus, 2 related members of the Bocavirus
genus in the Parvovirinae subfamily of the Parvoviridae
family, and it was provisionally named human bocavirus
(HBoV).
To investigate epidemiologic features of this virus and
further specify clinical signs associated with HBoV infec-
tions, we retrospectively tested respiratory specimens from
children obtained during a 1-year period. We report the
incidence and seasonal distribution of HBoV, provide a
phylogenetic analysis of HBoV isolates, and describe clin-
ical characteristics of HBoV infection.
The Study
The study sample comprised 589 children <5 years of
age who were admitted to a pediatric unit of the University
Hospital of Montpellier (France) for acute respiratory tract
disease, from November 2003 to October 2004. They were
306 boys and 283 girls with a median age of 7 months
(range 2 days–60 months). Nasopharyngeal aspirates from
these children were tested for common viral respiratory
pathogens as previously described (5). Samples were test-
ed for respiratory viruses by direct immunofluorescence
assays with monoclonal antibodies to RSV; influenza A
and B viruses; parainfluenza type 1, 2, and 3 viruses; and
human adenovirus. Samples were also injected into MRC5
cell monolayers for virus isolation, and they were tested
for HMPV by reverse transcription PCR. Aliquots of sam-
ples and of nucleic acid extracts were stored at −80°C.
Nucleic acid extracts were tested for HBoV DNA by
PCR with primers targeting the predicted NP1 gene (2). A
negative control was included in each PCR run. All HBoV-
positive samples were quantitated by real-time PCR with a
second sample aliquot. For quantitating HBoV DNAin the
positive samples, the 354-bp NP1 PCR fragment was
cloned into pGEM-T Easy Vector (Promega,
Charbonnières, France). The obtained HBoV-NP1 plasmid
was used as control in a subsequent 5′-exonuclease-based
real-time PCR assay performed on a LightCycler 2.0
(Roche Diagnostics, Meylan, France) with 2 inner primers
(BocaRT1, 5′-CGAAGATGAGCTCAGGGAAT-3′ and
BocaRT2, 5′-GCTGATTGGGTGTTCCTGAT-3′) and a
FAM/TAMRA dually labeled probe (5′-FAM-CACA-
GGAGCAGGAGCCGCAG TAMRA-3′). Amplification
was performed on 10 µL nucleic acid extract with 0.5
µmol/L both primers and probe and 3 mmol/L MgCl2 with
FastStart DNA Hybridization Mix (Roche Diagnostics).
For quantitation, standard curves were generated by 10-
fold dilutions of the pGEM-T HBoV NP1 plasmid.
Sensitivity of the PCR assay was 50 copies per reaction as
determined by dilutions of the plasmid. DNA level in the
HboV-positive samples was measured by using the
LightCycler control DNAkit (Roche Diagnostics). Results
were expressed as log HBoV DNAcopies per nanogram of
extracted DNA.
We identified 268 viruses in 259 (44.0%) of the 589
children. Of the 589 children, 165 (28.0%) were infected
with RSV, 50 (8.5%) with HMPV, 18 (3.1%) with influen-
za A viruses, 18 (3.1%) with rhinoviruses, 9 (1.5%) with
parainfluenza type 3 viruses, and 8 (1.3%) with human
adenoviruses.
Nasopharyngeal aspirates were positive for HBoVin 26
children (4.4%). Among these HBoV-infected children, 9
(34.6%) were coinfected with another respiratory virus: 5
with RSV, 2 with HMPV, and 2 with human adenovirus.
The median HBoV viral load was 2.61 log copies/ng of
DNA (range 1.26–4.26 log copies/ng of DNA). The sea-
sonal distribution of respiratory viruses is shown in
Figure 1; HBoV was detected from December to June.
Seven HBoV isolates (corresponding to 1 isolate per
month) were selected for sequence analysis of a 1-kb
DNA fragment encompassing the VP2 gene.
Amplification and sequencing primers were as follows:
BocaSEQ1 (5′-AAAATGAACTAGCAGATCTTGATG-
3′), BocaSEQ4 (5′-GAACTTGTAAGCAGAAGCAAAA
3′), BocaSEQ2 (5′-GTCTGGTTTCCTTTGTATAGGAGT-
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*Montpellier University Hospital, Montpellier, France3′), and BocaSEQ3 (5′-GACCCAACTCCTATACAAAG-
GAAAC-3′). These HBoV VP2 sequences were deposited
in GenBank under accession numbers AM160609 to
AM160615. The nucleotide sequences were aligned, and
a phylogenetic tree was constructed to include the 2 pre-
viously deposited HBoV sequences ST1 and ST2 as well
as the VP2 sequences of canine minute virus
(NC_004442) and bovine parvovirus (NC_001540). The
VP2 gene of human parvovirus B19 (NC_000883) was
chosen as outgroup to root this tree (Figure 2). Our VP2
sequences shared 97.5%–100% nucleotide identity with
the HBoV prototype strains ST1 and ST2, whereas amino
acid identity was 98.9%–100%.
The 26 HBoV-infected children had a median age of 13
months, and the ratio of boys to girls was 1.9. The median
duration of hospital stay was 4 days (range 2–39 days).
Bronchiolitis was the leading diagnosis, and upper respira-
tory pathologic features were uncommon. The clinical
signs and symptoms among children with HBoV are
shown in the Table. The predominant symptoms were dys-
pnea, respiratory distress, and cough. Half of the children
had fever (temperature >38°C). Chest radiographs were
obtained for 18 HBoV-infected children, and 15 of them
(83.3%) showed abnormal findings, such as hyperinflation
or interstitial infiltrates. History of asthma or previous
bronchiolitis episodes were reported in 6 HBoV-infected
children (23.0%). Three children (11.5%) had an underly-
ing disease (1 congenital heart disease and 2 chronic respi-
ratory diseases), and 7 (26.9%) were born preterm (<36
weeks). Laboratory parameters such as oxygen saturation,
C-reactive protein level, or leukocyte count were not rele-
vant in this context.
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Figure 1. Seasonal distribution of infections caused by human
bocavirus (HBoV), human metapneumovirus (HMPV), respiratory
syncytial virus (RSV), influenza Avirus, and other respiratory virus-
es during the 1-year study period (November 2003–October
2004). *Other viruses include parainfluenza virus type 3, human
adenoviruses, and picornaviruses.
Figure 2. Phylogenetic analysis of human bocavirus (HBoV) VP2
sequences. Viruses detected in the present study are prefixed
HBoV-MPT, followed by the isolate number (GenBank accession
nos. AM160609 to AM160615). The nucleotide sequences were
aligned with the ClustalW software. Phylogenetic trees were con-
structed by neighbor-joining through the Institut Pasteur website
(http://www.pasteur.fr) with the DNADist and neighbor-joining soft-
ware packages of the PHYLIP program. The default transition to
transversion ratio of 2.0 was retained. We computed 100 bootstrap
datasets with random sequence addition to generate consensus
trees. BPV, bovine parvovirus; MVC, canine minute virus (minute
virus of canine).Conclusions
Our data indicate that among children <5 years of age
hospitalized with a community-acquired respiratory tract
infection, HBoV was detected in 4.4% and represented the
third most likely etiologic agent after RSV and HMPV.
This 4.4% incidence is in accordance with the values of
3.1%, 5.6%, and 5.7% reported by Allander et al. (2),
Sloots et al. (3), and Ma et al. (4). HBoV was detected
from December to June, which suggests an epidemiologic
difference with respiratory viruses such as RSV, HMPV, or
influenza A virus (Figure 1). The absence of HBoV circu-
lation during summer and early fall needs further confir-
mation. Indeed, this finding might be in part explained by
the low number of samples collected during this period.
We previously showed that the HBoV NP1 gene dis-
played limited sequence variation (6). In the present study,
we also observed only minor sequence variations in the
VP2 gene, which suggests that the diverse strains of HBoV
belong to a unique lineage. This low genetic diversity of
HboV was also reported by Sloots et al., who analyzed the
NS1 gene (3).
HBoV infections were mainly identified in children
with lower respiratory tract diseases such as bronchiolitis.
HBoV was also found in children with asthma exacerba-
tion and, less frequently, in children with upper respirato-
ry infection, which suggests that HBoV shares clinical
features with respiratory viruses such as RSV or HMPV
(5,7). Underlying diseases, asthma, or previous bronchioli-
tis episodes as well as history of prematurity were
observed in 61.5% of HBoV-infected children. Even
though this feature may be explained by more systematic
hospitalization of these children, HBoV pathogenicity may
be facilitated by predisposing conditions.
In 9 (34.6%) instances, HBoV was detected concurrent-
ly with another respiratory virus. In the original descrip-
tion of HBoV, 17.6% of coinfections involved human
adenovirus or RSV (2). More recently, a high rate of coin-
fection (55.6%) was seen in a population of children <3
years of age (3). Considering these high rates of coinfec-
tion, the exact role played by HBoV in respiratory tract
diseases needs to be more precisely defined.
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